Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Investors with significant funds have taken a bullish position in Thermo Fisher Scientific (NYSE:TMO), a development that retail traders should be aware of.
This was brought to our attention today through our monitoring of publicly accessible options data at Benzinga. The exact nature of these investors remains a mystery, but such a major move in TMO usually indicates foreknowledge of upcoming events.
Today, Benzinga's options scanner identified 8 options transactions for Thermo Fisher Scientific. This is an unusual occurrence. The sentiment among these large-scale traders is mixed, with 62% being bullish and 0% bearish. Of all the options we discovered, 7 are puts, valued at $336,100, and there was a single call, worth $36,400.
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $580.0 to $610.0 for Thermo Fisher Scientific during the past quarter.
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Thermo Fisher Scientific's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Thermo Fisher Scientific's substantial trades, within a strike price spectrum from $580.0 to $610.0 over the preceding 30 days.
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
TMO | PUT | TRADE | BULLISH | 01/17/25 | $35.4 | $34.3 | $34.3 | $580.00 | $85.7K | 611 | 0 |
TMO | PUT | TRADE | BULLISH | 12/20/24 | $38.5 | $32.9 | $34.1 | $580.00 | $51.1K | 425 | 0 |
TMO | PUT | TRADE | NEUTRAL | 12/20/24 | $34.2 | $31.2 | $32.6 | $580.00 | $45.6K | 425 | 36 |
TMO | PUT | TRADE | BULLISH | 01/17/25 | $35.6 | $32.6 | $33.7 | $580.00 | $43.8K | 611 | 25 |
TMO | PUT | TRADE | NEUTRAL | 01/17/25 | $34.5 | $32.8 | $33.7 | $580.00 | $40.4K | 611 | 38 |
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of end-2023 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (10%); life science solutions (23%); and lab products and services, which includes CRO services (54%).
In light of the recent options history for Thermo Fisher Scientific, it's now appropriate to focus on the company itself. We aim to explore its current performance.
In the last month, 1 experts released ratings on this stock with an average target price of $650.0.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Thermo Fisher Scientific with Benzinga Pro for real-time alerts.
Posted In: TMO